03 Mar The Economic Impact of Reliance on an African Medicines Regulatory Authority
Posted at 11:01h
in
Background and Objectives The inherited backlog of 16,000 medicines applications of the South African Health Products Regulatory Authority (SAHPRA) was cleared through facilitated review pathways that included reliance on prior work by trusted regulators. This research aimed at determining the economic impact of reliance on national regulatory authorities (NRAs) in terms of lower assessors’ costs, especially to offset the financial efforts required to attain a higher World Health Organization (WHO) maturity level and understanding the way fees can sustain NRA activities.
Download latest version
Version:
1
Date Updated:
10/02/2025
File Type:
pdf
Category:
Published papers